Evidence map›Paper›PMID 26478868›Full record

ArticleResearch and reports in biochemistry

The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective.

Junjie Xing, Amanda R Titus, Mary Beth Humphrey

Open access · diamondAbstract read
In one paragraph

Article in Research and reports in biochemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. A novel homozygousThe Journal of international medical research · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. International journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Junjie XingDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA ; Department of Microbiology and immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Amanda R TitusDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mary Beth HumphreyDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA ; Department of Microbiology and immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA ; Department of veteran's Affairs, Oklahoma City, OK, USA.
University of Oklahoma Health Sciences Center · US

Funding

Mechanism of ITAM Signal Regulation in OsteoclastsR01DE019398 · NIDCR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HUMPHREY, MARY BETH · 2008 to 2012
$1.3M
NIDCR NIH HHS R01 DE019398
6 · The paper itself

Abstract

Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is a rare recessively inherited disease that is associated with early dementia and bone cysts with fractures. Here, we review the genetic causes of PLOSL with loss-of-function mutations or deletions in one of two genes,

Indexed as

Alzheimer'sdementialeukoencephalopathylipomembranousmicrogliapolycystic

Identifiers

PMID26478868
PMCPMC4605443
OpenAlexW2022794439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.